Sherley Wang

Ms. Sherley Wang
Pharmacovigilance (PV) Director

Ms. Sherley Wang brings over 16 years of experience in the pharmaceutical industry, including 11 years in pharmacovigilance and 5 years in clinical quality assurance. She has conducted more than 150 audits of hospital research centers and 100 audits of CROs and pharmaceutical companies, working with leading multinational organizations. Sherley serves as an authorised RPPV/QPPV for several domestic companies and plays a pivotal role in the development and oversight of compliant PV systems.

She authored the China Pharmacovigilance Industry Research Report 2024 and co-translated key pharmacovigilance texts in partnership with the CDE of the NMPA. A recognised industry expert, Sherley is a panelist for the China Food and Drug Industries Quality and Safety Promotion Association (FDSA) and teaches pharmacovigilance to graduate students at Tongji Medical College, Huazhong University of Science and Technology.

As a member of the China Institute of Internal Audit (CIIA), she is highly proficient in GCP, GVP, supplier audits, and regulatory inspections. Her expertise spans both domestic and international regulatory landscapes.